Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker MLTX
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 27, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 1,100 | $20.00 | $22.0K Sale | Form 4 ↗ |
| Jul 22, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 2,448 | $20.00 | $49.0K Sale | Form 4 ↗ |
| Jul 21, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 50,000 | $20.02 | $1.0M Sale | Form 4 ↗ |
| Jul 20, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 43,700 | $20.09 | $877.9K Sale | Form 4 ↗ |
| Jul 15, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 16,105 | $20.01 | $322.3K Sale | Form 4 ↗ |
| Jul 10, 2026 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 68,289 | $20.02 | $1.4M Sale | Form 4 ↗ |
| Jul 9, 2026 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 33,936 | $20.01 | $679.1K Sale | Form 4 ↗ |
| Jul 1, 2026 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 47,775 | $20.03 | $956.9K Sale | Form 4 ↗ |
| Jun 22, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 39,120 | $22.04 | $862.2K Sale | Form 4 ↗ |
| Jun 18, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 2,794 | $19.60 | $54.8K Sale | Form 4 ↗ |
| Jun 17, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 15,082 | $19.68 | $296.8K Sale | Form 4 ↗ |
| Jun 17, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 50,000 | $19.43 | $971.5K Sale | Form 4 ↗ |
| Jun 16, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 50,000 | $18.70 | $935.0K Sale | Form 4 ↗ |
| Jun 15, 2026 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 50,000 | $18.89 | $944.5K Sale | Form 4 ↗ |
| May 11, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 13,653 | $20.02 | $273.3K Sale | Form 4 ↗ |
| Apr 14, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 2,426 | $19.56 | $47.5K Sale | Form 4 ↗ |
| Apr 13, 2026 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 51,873 | $18.23 | $945.6K Sale | Form 4 ↗ |
| Apr 10, 2026 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 98,127 | $18.41 | $1.8M Sale | Form 4 ↗ |
| Apr 10, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 1,925 | $19.51 | $37.6K Sale | Form 4 ↗ |
| Apr 9, 2026 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Sale | 85,870 | $18.94 | $1.6M Sale | Form 4 ↗ |
| Mar 31, 2026 | Mark N. Lampert Director, 10% owner | MLTX MoonLake Immunotherapeutics | Sale | 248,530 | $16.79 | $4.2M Sale | Form 4 ↗ |
| Mar 31, 2026 | Mark N. Lampert Director, 10% owner | MLTX MoonLake Immunotherapeutics | Sale | 1.57M | $16.79 | $26.3M Sale | Form 4 ↗ |
| Mar 31, 2026 | Mark N. Lampert Director, 10% owner | MLTX MoonLake Immunotherapeutics | Sale | 1.93M | $16.79 | $32.4M Sale | Form 4 ↗ |
| Dec 9, 2025 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 70,000 | $14.49 | $1.0M Sale | Form 4 ↗ |
| Dec 9, 2025 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 72,908 | $14.43 | $1.1M Sale | Form 4 ↗ |
| Dec 8, 2025 | da Silva Jorge Santos Chief Executive Officer, Director | MLTX MoonLake Immunotherapeutics | Sale | 130,000 | $15.08 | $2.0M Sale | Form 4 ↗ |
| Dec 8, 2025 | Kristian Reich Chief Scientific Officer | MLTX MoonLake Immunotherapeutics | Sale | 130,000 | $15.08 | $2.0M Sale | Form 4 ↗ |
| Oct 8, 2025 | Matthias Bodenstedt Chief Financial Officer | MLTX MoonLake Immunotherapeutics | Buy | 10,870 | $9.09 | $98.8K Buy | Form 4 ↗ |
| Sep 30, 2025 | Cormorant Global Healthcare Master Fund, LP | MLTX MoonLake Immunotherapeutics | Sale | 5,827 | $6.96 | $40.6K Sale | Form 4 ↗ |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | MLTX MoonLake Immunotherapeutics | Sale | 2.80M | $6.61 | $18.5M Sale | Form 4 ↗ |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | MLTX MoonLake Immunotherapeutics | Sale | 3.39M | $7.58 | $25.7M Sale | Form 4 ↗ |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | MLTX MoonLake Immunotherapeutics | Sale | 232,460 | $8.40 | $2.0M Sale | Form 4 ↗ |
| Sep 29, 2025 | Cormorant Global Healthcare Master Fund, LP | MLTX MoonLake Immunotherapeutics | Sale | 70,748 | $9.38 | $663.6K Sale | Form 4 ↗ |
| Jul 3, 2025 | Catherine Moukheibir Director | MLTX MoonLake Immunotherapeutics | Sale | 23,500 | $48.79 | $1.1M Sale | Form 4 ↗ |
| Oct 4, 2024 | Simon Sturge Director | MLTX MoonLake Immunotherapeutics | Sale | 171,000 | $53.72 | $9.2M Sale | Form 4 ↗ |
| Oct 4, 2024 | BVF I GP LLC Director, 10% owner | MLTX MoonLake Immunotherapeutics | Sale | 132,549 | $50.00 | $6.6M Sale | Form 4 ↗ |
| Oct 4, 2024 | BVF I GP LLC Director, 10% owner | MLTX MoonLake Immunotherapeutics | Sale | 836,862 | $50.00 | $41.8M Sale | Form 4 ↗ |
| Oct 4, 2024 | BVF I GP LLC Director, 10% owner | MLTX MoonLake Immunotherapeutics | Sale | 1.03M | $50.00 | $51.5M Sale | Form 4 ↗ |
38 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:27 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances